GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.450
-0.050 (-3.33%)
At close: Jul 24, 2026, 4:00 PM EDT
1.470
+0.020 (1.38%)
After-hours: Jul 24, 2026, 7:00 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $2.57 million as of July 24, 2026. Its market cap has decreased by -49.59% in one year.
Market Cap
2.57M
Enterprise Value
-8.42M
1-Year Change
-49.59%
Ranking
Category
Stock Price
$1.45
ChartMarket Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $2.57M, a decrease of -89.85%. That is a compound annual growth rate of -50.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 2.57M | 2.80% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 3.32M |
| Propanc Biopharma | 3.29M |
| HCW Biologics | 3.21M |
| SciSparc | 3.17M |
| Creative Medical Technology Holdings | 3.01M |
| GeoVax Labs | 2.97M |
| Decoy Therapeutics | 2.77M |
| Virax Biolabs Group | 2.54M |